TENAX THERAPEUTICS, INC. - Common Stock (TENX)

CUSIP: 88032L605

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-600,269
SEC-reported price per share
$1.89
Number of holders
16
Value change
-$10,792,702
Number of buys
12
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
37,397,173

Security key

88032L605

Report period

Q3 2026

Institutions

16

Top holders

10

Ownership snapshot

Top reported holders of TENX - TENAX THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
15/15
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 14% 13D/G row: ADAR1 Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

ADAR1 Capital Management, LLC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAR1 Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
ADAR1 Capital Management, LLC 14%
BIOTECHNOLOGY VALUE FUND L P 10%
Janus Henderson Group Ltd. 10%
RTW INVESTMENTS, LP 9.9%
Vestal Point Capital, LP 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAR1 Capital Management, LLC
13D/G 13F
Company
14%
Reported 13D/G · 31 Aug 2026
$9,621,022
5,257,389 shares
$0 31 Aug 2026
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
10%
Reported 13D/G · 30 Jun 2026
$49,703,601
3,110,363 shares
+$19,202,223 30 Jun 2026
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
10%
Reported 13D/G · 28 Nov 2025
$4,172,774
623,733 shares
+$3,057,778 28 Nov 2025
RTW INVESTMENTS, LP
13D/G 13F
Company
9.9%
Reported 13D/G · 30 Jun 2026
$45,809,131
2,866,654 shares
+$15,964,404 30 Jun 2026
Vestal Point Capital, LP
13D/G 13F
Company
9.9%
Reported 13D/G · 30 Sep 2024
$18,525,720
2,470,096 shares
$0 30 Sep 2024
Vivo Opportunity Fund Holdings, L.P.
13D/G
9%
Reported 13D/G · 30 Jun 2026
$55,264,065
3,458,327 shares
$0 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
1,124,092
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q4 2025 Across Filers

Q4 2025 holders
48
Q3 2026 holders
16
Holder diff
-32
Investor Q4 2025 Shares Q3 2026 Shares Share Diff Share Chg % Q4 2025 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .